In conclusion, the present study demonstrated that ADPN treatment is effective in attenuation of cerebral ischemia-reperfusion injury, and HIF-1α-regulated antioxidant response is the main molecular mechanism responsible for ADPN treatment for stroke. This evidence concerns the gene HIF1A and Stroke.